Ignite Creation Date:
2024-05-06 @ 2:51 AM
Last Modification Date:
2024-10-26 @ 11:24 AM
Study NCT ID:
NCT02142868
Status:
NO_LONGER_AVAILABLE
Last Update Posted:
2018-12-21
First Post:
2014-05-16
Brief Title:
Expanded Access Study Of Palbociclib PD-0332991 In Combination With Letrozole As Treatment Of Post-Menopausal Women With HR-Positive Her2-Negative Advanced Breast Cancer For Whom Letrozole Therapy Is Deemed Appropriate
Sponsor:
Organization:
Pfizer